Latest Insider Transactions at Edwards Lifesciences Corp (EW)
This section provides a real-time view of insider transactions for Edwards Lifesciences Corp (EW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Edwards Lifesciences Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Edwards Lifesciences Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 03
2022
|
Bernard J Zovighian CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,150
+9.08%
|
-
|
|
Apr 29
2022
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.37%
|
-
|
|
Apr 29
2022
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-13.62%
|
-
|
|
Apr 29
2022
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-5.82%
|
$3,482,850
$107.88 P/Share
|
|
Apr 29
2022
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+26.6%
|
$946,050
$21.76 P/Share
|
|
Apr 28
2022
|
Martha H. Marsh Director |
SELL
Open market or private sale
|
Direct |
28,722
-51.75%
|
$3,101,976
$108.09 P/Share
|
|
Apr 28
2022
|
Martha H. Marsh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
28,722
+34.1%
|
$718,050
$25.99 P/Share
|
|
Apr 11
2022
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
20,000
-16.27%
|
$2,440,000
$122.16 P/Share
|
|
Apr 11
2022
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+29.6%
|
$420,000
$21.76 P/Share
|
|
Apr 08
2022
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct |
11,660
-3.56%
|
$1,434,180
$123.43 P/Share
|
|
Apr 08
2022
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
11,660
+6.64%
|
$244,860
$21.76 P/Share
|
|
Apr 08
2022
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
3,675
-3.61%
|
$452,025
$123.07 P/Share
|
|
Apr 08
2022
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
3,675
+3.48%
|
$128,625
$35.2 P/Share
|
|
Apr 08
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-8.39%
|
$1,359,150
$123.21 P/Share
|
|
Apr 08
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.03%
|
$232,050
$21.76 P/Share
|
|
Apr 05
2022
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,242
-1.19%
|
$876,282
$121.3 P/Share
|
|
Apr 05
2022
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,242
+3.41%
|
$260,712
$36.75 P/Share
|
|
Apr 04
2022
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
15,488
+5.95%
|
-
|
|
Apr 04
2022
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
15,488
-42.07%
|
-
|
|
Mar 22
2022
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.37%
|
-
|
|
Mar 22
2022
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-7.59%
|
$3,613,050
$111.4 P/Share
|
|
Mar 22
2022
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-10.9%
|
-
|
|
Mar 22
2022
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+26.6%
|
$946,050
$21.76 P/Share
|
|
Mar 14
2022
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
20,000
-23.68%
|
$2,080,000
$104.59 P/Share
|
|
Mar 14
2022
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+29.67%
|
$420,000
$21.76 P/Share
|
|
Mar 11
2022
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct |
11,660
-3.62%
|
$1,235,960
$106.06 P/Share
|
|
Mar 11
2022
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
11,660
+6.65%
|
$244,860
$21.76 P/Share
|
|
Mar 11
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-8.55%
|
$1,171,300
$106.02 P/Share
|
|
Mar 11
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.08%
|
$232,050
$21.76 P/Share
|
|
Mar 08
2022
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,242
-1.19%
|
$767,652
$106.38 P/Share
|
|
Mar 08
2022
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,242
+3.42%
|
$260,712
$36.75 P/Share
|
|
Mar 08
2022
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
3,675
-3.61%
|
$393,225
$107.6 P/Share
|
|
Mar 08
2022
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
3,675
+3.49%
|
$128,625
$35.2 P/Share
|
|
Feb 21
2022
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-0.86%
|
$33,495
$105.62 P/Share
|
|
Feb 18
2022
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
20,000
-23.44%
|
$2,120,000
$106.18 P/Share
|
|
Feb 18
2022
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+29.67%
|
$420,000
$21.76 P/Share
|
|
Feb 15
2022
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.37%
|
-
|
|
Feb 15
2022
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-14.99%
|
$3,580,500
$110.27 P/Share
|
|
Feb 15
2022
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-10.64%
|
-
|
|
Feb 15
2022
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+26.6%
|
$946,050
$21.76 P/Share
|
|
Feb 11
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-8.24%
|
$1,226,550
$111.74 P/Share
|
|
Feb 11
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.08%
|
$232,050
$21.76 P/Share
|
|
Feb 08
2022
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.08%
|
$698,500
$110.2 P/Share
|
|
Feb 08
2022
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.73%
|
$133,350
$21.76 P/Share
|
|
Feb 08
2022
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
4,386
-1.09%
|
$478,074
$109.9 P/Share
|
|
Feb 08
2022
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
4,386
+2.13%
|
$157,896
$36.75 P/Share
|
|
Feb 08
2022
|
Kieran Gallahue Director |
SELL
Open market or private sale
|
Direct |
32,256
-90.38%
|
$3,548,160
$110.79 P/Share
|
|
Feb 08
2022
|
Kieran Gallahue Director |
BUY
Exercise of conversion of derivative security
|
Direct |
32,256
+47.47%
|
$709,632
$22.29 P/Share
|
|
Jan 28
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-3.43%
|
$1,105,000
$100.47 P/Share
|
|
Jan 28
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+13.9%
|
$232,050
$21.76 P/Share
|